Scientific ReportsNeurosciencePeer-reviewed journal article
Retrograde transduction of dopaminergic cells in substantia nigra of rhesus monkey
Anya S. PlotnikovaiD, Walter LerchneriD, Alexander C. Cummins, Gang CheniD, Leonardo Salhani, Vincent D. CostaiD, Bruno B. AverbeckiD, Barry J. RichmondiD, Zayd M. KhaliqiD, Mark A. G. EldridgeiD
Abstract
Neuromodulatory systems regulate neural circuits across broad regions of the brain, and disruption of the dopaminergic system contributes to psychiatric and neurodegenerative disorders. Engineered viral vectors have been used to target the neuromodulatory systems of the nonhuman primate brain (Y. Chen et al., 2023; El-Shamayleh et al., 2016; Gray et al., 2010; Lerchner et al., 2014; Perez et al., 2022). However, a conspicuous obstacle to the isolation and modulation of specific pathways is the inability of many retrogradely infecting viruses to transduce dopaminergic (DA) cells efficiently (Tervo et al., 2016; Cushnie et al., 2020; Weiss et al., 2020). We compare the DA neuron retrograde transduction efficacy of four viral vectors after injection into the striatum of nonhuman primates (NHP). Selectivity was assessed by comparing the neuronal co-expression of fluorescent reporter protein and tyrosine-hydroxylase (TH) antibody in substantia nigra pars compacta (SNc). The rabies pseudotyped lentiviral vector, FuG-B2, produced superior retrograde transduction of DA cells to FuG-C or FuG-E. AAV2.retro was the least effective.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 40th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegeneration
Sofia Ines Garcia Moreno, Fabian Limani, … Thomas Steinkellner·Experimental NeurologyPeer-reviewed·Sep 15, 2024
- Intra-striatal AAV2.retro administration leads to extensive retrograde transport in the rhesus macaque brain: implications for disease modeling and therapeutic development
Alison R. Weiss, William A. Liguore, … Jodi L. McBride·Scientific ReportsPeer-reviewed·Apr 24, 2020
- Development And Characterization Of A Non-Human Primate Model Of Disseminated Synucleinopathy
Alberto J. Rico, Almudena Corcho, … José Luis Lanciego·Frontiers in NeuroanatomyPeer-reviewed·Mar 27, 2024
- Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates
Julia Chocarro, Alberto J. Rico, … José Luis Lanciego·BrainPeer-reviewed·Sep 28, 2023
- A viral vector model for circuit-specific synucleinopathy
Alexia Lantheaume, Nina Schöneberg, … Philip Tovote·bioRxiv·Aug 28, 2023
- Site-Specific Noninvasive Delivery of Retrograde Viral Vectors to the Brain
Manwal Harb, Shirin Nouraein, Jerzy O. Szablowski·Bioengineering & Translational MedicinePeer-reviewed·Aug 21, 2025